Fisher Asset Management’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.31M Buy
58,899
+21
+0% +$466 ﹤0.01% 648
2025
Q1
$1.09M Hold
58,878
﹤0.01% 664
2024
Q4
$780K Sell
58,878
-3,070
-5% -$40.6K ﹤0.01% 701
2024
Q3
$2.08M Sell
61,948
-3,044
-5% -$102K ﹤0.01% 577
2024
Q2
$1.63M Sell
64,992
-5,662
-8% -$142K ﹤0.01% 619
2024
Q1
$1.59M Sell
70,654
-500
-0.7% -$11.3K ﹤0.01% 632
2023
Q4
$1.52M Buy
71,154
+500
+0.7% +$10.7K ﹤0.01% 634
2023
Q3
$1.27M Hold
70,654
﹤0.01% 701
2023
Q2
$1.44M Hold
70,654
﹤0.01% 709
2023
Q1
$1.54M Sell
70,654
-6,896
-9% -$150K ﹤0.01% 693
2022
Q4
$2.4M Hold
77,550
﹤0.01% 620
2022
Q3
$1.98M Buy
77,550
+10
+0% +$255 ﹤0.01% 575
2022
Q2
$1.57M Buy
77,540
+9,651
+14% +$196K ﹤0.01% 565
2022
Q1
$1.68M Buy
67,889
+8,468
+14% +$210K ﹤0.01% 575
2021
Q4
$2.07M Buy
59,421
+13,402
+29% +$466K ﹤0.01% 553
2021
Q3
$1.25M Buy
+46,019
New +$1.25M ﹤0.01% 581